Contact Information

Currently Enrolling Trials

General Information

Clonazepam has been approved as an anticonvulsant to be manufactured in 0.5mg, 1mg and 2mg tablets. It is the generic equivalent of Roche Laboratories' Klonopin.

Approval Date: 1998-01-01

Company Name: Watson Pharmaceuticals

Back to Listings

27Jan
Medical Device Clinical Trials in China: Latest Regulatory Developments
11Feb
Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era
23Mar
Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges
26Apr
MAGI's Clinical Research vConference — Spring 2021

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here

Clonazepam

Profile

Contact Information

Currently Enrolling Trials

General Information

Upcoming Events

Medical Device Clinical Trials in China: Latest Regulatory Developments

Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

MAGI's Clinical Research vConference — Spring 2021

Featured Products

Regenerative Medicine: Steps to Accelerate Development

Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

2021 Vaccine Industry Will Continue to be Dominated by COVID-19 Trials, Experts Say

COVID-19, Oncology, CNS and Infectious Disease Trials Will Dominate in 2021, Survey Predicts

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.